Lifecycle management for established pharma brands across four therapeutic areas
Pharmanovia acquires and re-engineers established pharmaceutical brands to extend their market life and improve patient outcomes. The tech stack—SAP, Databricks, AWS, Power BI, Salesforce—reflects a company in active finance and data transformation, with a senior-heavy hiring mix (14 of 27 tracked roles) concentrated in data, finance, and healthcare functions. Current projects around commercial dashboards, evidence generation, and a Databricks/AWS data platform suggest the company is building internal analytics and operational intelligence to support multi-market complexity.
Pharmanovia is a UK-based pharmaceutical lifecycle management company operating across endocrinology, neurology, cardiovascular, and oncology. Founded in 2013 and currently 201–500 employees, the company operates in over 160 countries, delivering products through in-house development and strategic partnerships. The business model centers on acquiring established brands, repurposing and re-engineering them, and licensing novel medicines—a strategy that generates supply chain, regulatory, and forecasting complexity. Current operational pain points span regulatory compliance across multiple markets, finance transformation, on-time shipment delivery, and demand forecasting accuracy.
Core systems include SAP, SAP S/4HANA, and SAP Concur for finance and operations; Databricks and AWS for data infrastructure; Power BI for analytics; Salesforce for CRM; and Informatica MDM for master data governance.
Endocrinology, neurology, cardiovascular, and oncology. The company serves patients globally through established brand lifecycle management and in-licensing of novel medicines.
Other companies in the same industry, closest in size